0001193805-22-000420.txt : 20220303 0001193805-22-000420.hdr.sgml : 20220303 20220303211435 ACCESSION NUMBER: 0001193805-22-000420 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rossi Michael A. CENTRAL INDEX KEY: 0001783869 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33957 FILM NUMBER: 22711831 MAIL ADDRESS: STREET 1: C/O HARVARD BIOSCIENCE, INC. STREET 2: 84 OCTOBER HILL ROAD #10 CITY: HOLLISTON STATE: MA ZIP: 01746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC CENTRAL INDEX KEY: 0001123494 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043306140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL RD CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: 5088938999 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD CITY: HOLLISTON STATE: MA ZIP: 01746 4 1 e621404_4-michael.xml X0306 4 2022-03-01 0 0001123494 HARVARD BIOSCIENCE INC HBIO 0001783869 Rossi Michael A. C/O HARVARD BIOSCIENCE, INC. 84 OCTOBER HILL ROAD HOLLISTON MA 01746 0 1 0 0 Chief Financial Officer Common Stock 2022-03-01 4 A 0 31021 0.00 A 255117 D Common Stock 2022-03-01 4 A 0 28716 0.00 A 283833 D Represents an award of 31,021 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. Includes (a) the award described in footnote (1) above, (b) 43,092 remaining restricted stock units that will vest on June 11, 2022 and 2023, (c) 25,641 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 36,876 restricted stock units with performance based vesting conditions, (e) 23,878 remaining restricted stock units that will vest on July 18, 2022, (f) 21,545 remaining restricted stock units that will vest on December 29, 2022 and 2023, and (g) 73,064 shares of common stock beneficially owned by the Reporting Person. Represents an award of 28,716 restricted stock units with performance based vesting conditions. These restricted stock units will vest upon the achievement of a relative total shareholder return of the Issuer's common stock during the period from March 1, 2022 to the earlier of (i) December 31, 2024, and (ii) the date of a change of control (the "Measurement Period"), measured relative to the Russell 2000 index and based on the 20-day trading average beginning on the first day of the Measurement Period and ending on the last day of the Measurement Period, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported. Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above. /s/ Michael A. Rossi 2022-03-03